Wave Life Sciences Ltd. - Ordinary Shares (WVE): Price and Financial Metrics

Wave Life Sciences Ltd. - Ordinary Shares (WVE): $4.84

0.03 (-0.62%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

WVE Price/Volume Stats

Current price $4.84 52-week high $7.67
Prev. close $4.87 52-week low $3.15
Day low $4.64 Volume 492,400
Day high $4.94 Avg. volume 856,336
50-day MA $5.41 Dividend yield N/A
200-day MA $5.04 Market Cap 591.85M

WVE Stock Price Chart Interactive Chart >


Wave Life Sciences Ltd. - Ordinary Shares (WVE) Company Bio


WAVE Life Sciences Pte. Ltd., a preclinical biopharmaceutical company, designs, develops, and commercializes nucleic acid therapeutic candidates. The company was founded in 2012 and is based in Simgapore.


WVE Latest News Stream


Event/Time News Detail
Loading, please wait...

WVE Latest Social Stream


Loading social stream, please wait...

View Full WVE Social Stream

Latest WVE News From Around the Web

Below are the latest news stories about WAVE LIFE SCIENCES LTD that investors may wish to consider to help them evaluate WVE as an investment opportunity.

Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy

FORWARD-53 is fully enrolled with potentially registrational dystrophin expression data expected in 2024 Previous clinical proof-of-concept data demonstrated highest level of exon skipping ever observed in the clinic and that WVE-N531 was present in myogenic stem cells, which are important for potential muscle regeneration CAMBRIDGE, Mass., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatme

Yahoo | December 15, 2023

Wave Life Sciences Ltd.'s (NASDAQ:WVE) recent 35% pullback adds to one-year year losses, institutional owners may take drastic measures

Key Insights Institutions' substantial holdings in Wave Life Sciences implies that they have significant influence over...

Yahoo | December 13, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!

William White on InvestorPlace | December 7, 2023

Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares

CAMBRIDGE, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today the pricing of its previously announced underwritten public offering of 20,000,000 of its ordinary shares at a price to the public of $5.00 per ordinary share. Gross proceeds to Wave Life Sciences from the offering are expected to be approximately $100 million, b

Yahoo | December 7, 2023

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

CAMBRIDGE, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it has commenced an underwritten public offering of $100 million in aggregate of its ordinary shares, and, to certain investors that so choose in lieu of ordinary shares, pre-funded warrants to purchase ordinary shares. In connection with the offering, Wave

Yahoo | December 6, 2023

Read More 'WVE' Stories Here

WVE Price Returns

1-mo -16.12%
3-mo 10.00%
6-mo -12.32%
1-year 20.40%
3-year -20.26%
5-year -82.54%
YTD -4.16%
2023 -27.86%
2022 122.93%
2021 -60.10%
2020 -1.81%
2019 -80.93%

Continue Researching WVE

Want to see what other sources are saying about Wave Life Sciences Ltd's financials and stock price? Try the links below:

Wave Life Sciences Ltd (WVE) Stock Price | Nasdaq
Wave Life Sciences Ltd (WVE) Stock Quote, History and News - Yahoo Finance
Wave Life Sciences Ltd (WVE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!